Synvent (Albuterol/Salbutamol)
Synvent HFA MDI contains short acting beta-2 agonist Albuterol sulphate (also Salbutamol sulphate) as active ingredient. It acquired license certificate in Taiwan and Hong Kong in 2013 and 2015, and is under the process of reviewing for other countries submission.